Answer:
D- Diathesis-stress model
Explanation:
Diathesis-stress model proposed that people are born with a genetic predisposition that places them at risk of developing a psychological disorder if exposed to certain extremely taxing life experiences because people may develop mental and physical disorders which develop from a genetic and they are combined with stressful conditions or extreme taxing life experiences that play facilitating role in their life . Example extreme taxing life experiences may be lack of money or hardness when growing up or severe illness, depression etc which might have place them at risk of developing a psychological disorder
because they were exposed to some certain stress caused by life experiences or extremely taxing life experience thereby resulting in mental health disorders
People are born with a genetic predisposition that places them at risk of developing a psychological disorder due to difficult life experiences.
Answer:
I think it's E
Explanation:
When reading the passage, we understand that the author opposes the first sentence. The second sentence would effectively validate the first statement if it were correct, in which case, it would make the author's point invalid.
A is not correct because the author does not support the first idea.
B is not correct because although the author actually contests the first sentence, the author does not accept the findings in the following sentence.
C is not correct since the author thinks the first sentence is invalid, but the second sentence does not validate that sentence.
D is not correct since both the first and second sentences oppose the author's opinion.
Afferent or sensory neurons collect stimuli received by receptors throughout the body, including the skin, eyes, ears, nose, and tongue as well as pain and other receptors in the internal organs. Sensory information is transmitted, which includes the brain and spinal cord.
Answer:
Prescription drugs marketed with a specific brand name by the company that manufactures it, usually the company which develops and patents it. When patents run out, generic versions of many popular drugs are marketed at lower cost by other companies.
Explanation: